Wolverine Trading
ALXN

Wolverine Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Wolverine Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,700
Closed -$2.41M – 7101
2021
Q1 		$2.41M Sell
15,700
-33,900
-68% -$5.24M ﹤0.01% 1757
2020
Q4 		$7.75M Sell
49,600
-9,200
-16% -$1.18M 0.01% 815
2020
Q3 		$6.61M Buy
58,800
+2,600
+5% +$280K 0.02% 711
2020
Q2 		$6.25M Buy
56,200
+900
+2% +$95.5K 0.02% 695
2020
Q1 		$4.83M Buy
55,300
+4,600
+9% +$451K 0.01% 784
2019
Q4 		$5.44M Sell
50,700
-34,200
-40% -$3.66M 0.01% 1031
2019
Q3 		$8.3M Buy
84,900
+2,000
+2% +$225K 0.02% 617
2019
Q2 		$10.9M Buy
82,900
+48,000
+138% +$6.19M 0.03% 496
2019
Q1 		$4.72M Sell
34,900
-2,000
-5% -$249K 0.01% 915
2018
Q4 		$3.59M Sell
36,900
-2,500
-6% -$296K 0.01% 1012
2018
Q3 		$5.48M Sell
39,400
-54,700
-58% -$6.86M 0.01% 895
2018
Q2 		$10.5M Hold
94,100
– – 0.03% 478
2018
Q1 		$10.5M Buy
+94,100
New +$11.2M 0.03% 478
2017
Q4 		– Sell
-98,900
Closed -$13.9M – 5744
2017
Q3 		$13.9M Buy
98,900
+44,000
+80% +$5.98M 0.05% 305
2017
Q2 		$6.72M Buy
54,900
+43,700
+390% +$5.09M 0.03% 535
2017
Q1 		$1.37M Sell
11,200
-17,400
-61% -$2.24M 0.01% 1466
2016
Q4 		$3.5M Buy
28,600
+5,400
+23% +$661K 0.02% 947
2016
Q3 		$2.79M Buy
+23,200
New +$2.99M 0.01% 1091

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Wolverine Trading's ALXN Position: Q2 2021 in Review

Wolverine Trading sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 2,917 shares — an estimated $448K sold.

Wolverine Trading first reported a position in ALXN in Q3 2016 and held it in 13 quarters. The position peaked at $2.68M in Q2 2018. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Wolverine Trading reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 2,917 Alexion Pharmaceuticals shares in Q2 2021, an estimated $448K.
  • Wolverine Trading first reported a position in Alexion Pharmaceuticals in Q3 2016 and held it in 13 quarters.
  • Wolverine Trading's Alexion Pharmaceuticals position peaked at $2.68M in Q2 2018.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.